搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Streptococcus pneumoniae Glycerol-3-phosphate dehydrogenase [NAD (P)+] CSB-YP534190FNA
CSB-EP534190FNA
CSB-BP534190FNA
CSB-MP534190FNA
CSB-EP534190FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Tyrosine--tRNA ligase (tyrS) CSB-YP534191FNA
CSB-EP534191FNA
CSB-BP534191FNA
CSB-MP534191FNA
CSB-EP534191FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae UPF0398 protein SPH_0478 (SPH_0478) CSB-YP534192FNA
CSB-EP534192FNA
CSB-BP534192FNA
CSB-MP534192FNA
CSB-EP534192FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 3-oxoacyl-[acyl-carrier-protein] synthase 3 (fabH) CSB-YP534193FNA
CSB-EP534193FNA
CSB-BP534193FNA
CSB-MP534193FNA
CSB-EP534193FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Undecaprenyl-diphosphatase (uppP), partial CSB-YP534194FNA
CSB-EP534194FNA
CSB-BP534194FNA
CSB-MP534194FNA
CSB-EP534194FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae L-fucose isomerase (fucI), partial CSB-YP534195FNA
CSB-EP534195FNA
CSB-BP534195FNA
CSB-MP534195FNA
CSB-EP534195FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Heat-inducible transcription repressor HrcA (hrcA) CSB-YP534196FNA
CSB-EP534196FNA
CSB-BP534196FNA
CSB-MP534196FNA
CSB-EP534196FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae tRNA (guanine-N (7)-)-methyltransferase CSB-YP534197FNA
CSB-EP534197FNA
CSB-BP534197FNA
CSB-MP534197FNA
CSB-EP534197FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Polyribonucleotide nucleotidyltransferase (pnp), partial CSB-YP534198FNA
CSB-EP534198FNA
CSB-BP534198FNA
CSB-MP534198FNA
CSB-EP534198FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 30S ribosomal protein S2 (rpsB) CSB-YP534199FNA
CSB-EP534199FNA
CSB-BP534199FNA
CSB-MP534199FNA
CSB-EP534199FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Ribonuclease Z (rnz) CSB-YP534200FNA
CSB-EP534200FNA
CSB-BP534200FNA
CSB-MP534200FNA
CSB-EP534200FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 30S ribosomal protein S16 (rpsP) CSB-YP534201FNA
CSB-EP534201FNA
CSB-BP534201FNA
CSB-MP534201FNA
CSB-EP534201FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Phosphopentomutase (deoB) CSB-YP534202FNA
CSB-EP534202FNA
CSB-BP534202FNA
CSB-MP534202FNA
CSB-EP534202FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Deoxyribose-phosphate aldolase (deoC) CSB-YP534203FNA
CSB-EP534203FNA
CSB-BP534203FNA
CSB-MP534203FNA
CSB-EP534203FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 50S ribosomal protein L20 (rplT) CSB-YP534204FNA
CSB-EP534204FNA
CSB-BP534204FNA
CSB-MP534204FNA
CSB-EP534204FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Foldase protein prsA (prsA) CSB-YP534205FNA
CSB-EP534205FNA
CSB-BP534205FNA
CSB-MP534205FNA
CSB-EP534205FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 50S ribosomal protein L27 (rpmA) CSB-YP534206FNA
CSB-EP534206FNA
CSB-BP534206FNA
CSB-MP534206FNA
CSB-EP534206FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Ribonuclease HII (rnhB) CSB-YP534207FNA
CSB-EP534207FNA
CSB-BP534207FNA
CSB-MP534207FNA
CSB-EP534207FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Exodeoxyribonuclease 7 small subunit (xseB) CSB-YP534208FNA
CSB-EP534208FNA
CSB-BP534208FNA
CSB-MP534208FNA
CSB-EP534208FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Carbamoyl-phosphate synthase large chain (carB), partial CSB-YP534209FNA
CSB-EP534209FNA
CSB-BP534209FNA
CSB-MP534209FNA
CSB-EP534209FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€(xiàn)留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>